Tokman Alexander Y 4
4 · ENDRA Life Sciences Inc. · Filed Apr 13, 2020
Insider Transaction Report
Form 4
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2020-04-09+42,857→ 42,857 total
Footnotes (2)
- [F1]Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director Compensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day of each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes unvested restricted stock units.